About Xvivo Perfusion

Company Description

XVIVO is a medical technology company with headquarter in Gothenburg, Sweden, a production site in Lund, Sweden and office in Denver, USA. We are firmly rooted in medical science and our core business is in ex vivo organ preservation. We are focused on developing optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation. We have more than 20 years of experience within the transplant industry and are dedicated to providing more effective, clinically proven and innovative products that both increase the availability of acceptable donor organs and improve survival after transplantation.

Year founded

1998

Served area

Worldwide

Shareholder information

Shares outstanding

29,560,000

IPO

Oct. 8, 2012

Stock exchange(s)

Nasdaq Stockholm

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.